SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fredun Pharmaceuticals secures tender from TNMSC for supply of generic medicines

10 Apr 2025 Evaluate

Fredun Pharmaceuticals has been awarded a tender by the Tamil Nadu Medical Services Corporation (TNMSC) for the supply of generic medicines. The total value of the tender ranges between Rs 15 crore and Rs 18 crore. The supply of these goods is set to commence within the first quarter of FY26 and will extend over a period of 14 months.

The products will be part of the Fredun Gx brand, which is known for its dedication to excellence and reliability. This tender award from TNMSC not only reinforces its position in the market but also aligns with its mission to enhance access to essential medications for all.

Fredun Pharmaceuticals is engaged in manufacturing of pharmaceutical products.

Fredun Pharma Share Price

2043.90 -23.80 (-1.15%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×